Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling.
Shengqi WangJing LiShicui HongNeng WangShang XuBowen YangYifeng ZhengJuping ZhangBo PanYudie HuZhiyu WangPublished in: Journal of experimental & clinical cancer research : CR (2024)
as a novel dying cell-released signal and provide TPCA-1 as a targeting candidate to improve TNBC prognosis.